当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析 - 现金流量表

康缘药业

(600557)

  

流通市值:69.01亿  总市值:69.01亿
流通股本:5.66亿   总股本:5.66亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,731,538,655.22922,469,512.833,817,735,154.922,712,758,668.07
  收到的税费返还1,279,918.7---
  收到其他与经营活动有关的现金67,259,284.8127,531,153.12193,704,198.39149,901,098.29
  经营活动现金流入小计1,800,077,858.73950,000,665.954,011,439,353.312,862,659,766.36
  购买商品、接受劳务支付的现金343,887,276.54156,281,959.54660,974,490.89468,856,439.38
  支付给职工以及为职工支付的现金371,529,093.36207,744,867.43715,600,956.38545,390,647.88
  支付的各项税费175,590,848.59108,984,590.94328,513,432.41231,771,114.27
  支付其他与经营活动有关的现金826,970,237.02411,091,765.341,695,758,301.871,270,516,658.45
  经营活动现金流出小计1,717,977,455.51884,103,183.253,400,847,181.552,516,534,859.98
  经营活动产生的现金流量净额82,100,403.2265,897,482.7610,592,171.76346,124,906.38
二、投资活动产生的现金流量:
  收回投资收到的现金6,966,154.966,966,154.96599,243,952.44489,014,448.79
  取得投资收益收到的现金4,563,349.082,644,358.0810,262,586.574,924,048.57
  处置固定资产、无形资产和其他长期资产收回的现金净额189,902.4153,513.22,039,975.71,953,146.28
  投资活动现金流入小计11,719,406.449,764,026.24611,546,514.71495,891,643.64
  购建固定资产、无形资产和其他长期资产支付的现金286,712,048.22187,658,018.94521,777,876.87335,663,338.82
  投资支付的现金--603,600,000493,600,000
  投资活动现金流出小计286,712,048.22187,658,018.941,125,377,876.87829,263,338.82
  投资活动产生的现金流量净额-274,992,641.78-177,893,992.7-513,831,362.16-333,371,695.18
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金--91,900,000-
  支付其他与筹资活动有关的现金307,056-24,491,555.3923,149,927.55
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计307,056-116,391,555.3923,149,927.55
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-307,056--116,391,555.39-23,149,927.55
四、汇率变动对现金及现金等价物的影响-214,691.55-140,556.11-39,997.46-8,216.49
五、现金及现金等价物净增加额-193,413,986.11-112,137,066.11-19,670,743.25-10,404,932.84
  加:期初现金及现金等价物余额2,148,110,744.092,148,110,744.092,167,781,487.342,167,781,487.34
  期末现金及现金等价物余额1,954,696,757.982,035,973,677.982,148,110,744.092,157,376,554.5
补充资料:
  净利润152,876,787.83-307,304,612.7-
  资产减值准备--20,738,802.14-
  固定资产和投资性房地产折旧96,767,235.24-171,874,504.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧96,767,235.24-171,874,504.78-
  无形资产摊销9,605,045.97-19,353,561.92-
  长期待摊费用摊销6,820,126.35-7,309,177.68-
  处置固定资产、无形资产和其他长期资产的损失-32,604.34--429,202.97-
  固定资产报废损失1,001,495.81-1,351,966.28-
  财务费用6,713,208.88-14,280,881.52-
  投资损失-4,572,395.59--10,243,091.06-
  递延所得税-2,836,152.28-185,267.56-
  其中:递延所得税资产减少-2,836,152.28-185,267.56-
  存货的减少46,266,536.63-85,548,587.6-
  经营性应收项目的减少-149,828,221.42-218,940,916.07-
  经营性应付项目的增加-82,738,066.78--224,453,552.68-
  现金的期末余额1,954,696,757.98-2,148,110,744.09-
  减:现金的期初余额2,148,110,744.09-2,167,781,487.34-
  现金及现金等价物的净增加额-193,413,986.11--19,670,743.25-
公告日期2026-08-282026-04-302026-04-232025-10-31
审计意见(境内)标准无保留意见
TOP↑